Table 1.
Clinical and laboratory findings in arginine and placebo group before treatment.
| Sign and symptom | Group | P value | |
|---|---|---|---|
| Arginine N = 32 (%) |
Placebo N = 31 (%) |
||
| Age (mean ± SD) | 51.9 ± 22.8 | 52.3 ± 21.7 | 0.943 |
| Gender | |||
| Male | 15 (46.9) | 16 (51.6) | 0.704 |
| Female | 17 (53.1) | 15 (48.4) | |
| Resident | |||
| Rural | 14 (43.7) | 12 (38.7) | 0.682 |
| Urban | 18 (56.3) | 19 (61.3) | |
| Constitutional symptoms | 30 (93.8) | 29 (93.6) | 0.976 |
| Cough | 29 (90.6) | 28 (90.3) | 0.968 |
| BMI < 18.5 | 15 (46.9) | 14 (45.2) | 0.889 |
| Tuberculin test >10 mm | 27 (84.4) | 26 (83.8) | 0.96 |
| Sputum smear >1+ | 13 (40.6) | 13 (41.9) | 0.912 |
| Anemia* | 17 (53.1) | 16 (51.6) | 0.904 |
| ↑ ESR** mm/h | 28 (87.5) | 29 (93.6) | 0.412 |
| ↑ CRP*** | 24 (75) | 22 (71) | 0.719 |
*Hg <13 g/dl in men and Hg <12 g/dl in women.
**The normal range (Westergren method) for males is 0–15 mm/h and for females is 0–20 mm/h.
***CRP >10 mg/L.